Global Human Rabies Vaccine Competitive Landscape Professional Research Report 2024

Research Summary

The human rabies vaccine is a preventive measure against rabies, a deadly viral infection transmitted through the saliva of infected animals, primarily dogs. This vaccine induces active immunity by exposing the recipient's immune system to inactivated rabies virus particles. The standard rabies vaccination schedule involves multiple doses given over a few weeks, and booster shots are recommended for those at continued risk of exposure, such as veterinarians or travelers to regions where rabies is prevalent. The vaccine stimulates the production of antibodies, which can rapidly neutralize the virus if the person is later exposed. Post-exposure prophylaxis, including the rabies vaccine and human rabies immunoglobulin, is administered in the event of potential exposure to the virus, such as bites or scratches from animals suspected of being rabid. The human rabies vaccine has significantly contributed to the prevention of rabies, a disease that is almost universally fatal once clinical symptoms appear.

According to DIResearch's in-depth investigation and research, the global Human Rabies Vaccine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Human Rabies Vaccine include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, Ningbo Rongan Biological, ZhongKe Biopharm, Indian Immunologicals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Human Rabies Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Rabies Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Human Rabies Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Rabies Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Human Rabies Vaccine Include:

Bharat Biotech

Bavarian Nordic

Sanofi-Pasteur

Chengda Bio

KANGH

Prcmise

Henan Grand Biopharma

Zhuoyi Biological

Ningbo Rongan Biological

ZhongKe Biopharm

Indian Immunologicals

Human Rabies Vaccine Product Segment Include:

Vero Cell

BHK

Chick Embryo Cell

Human Diploid Cells

Others

Human Rabies Vaccine Product Application Include:

Pre-Exposure Vaccine

Post-Exposure Vaccine

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Human Rabies Vaccine Industry PESTEL Analysis

Chapter 3: Global Human Rabies Vaccine Industry Porter's Five Forces Analysis

Chapter 4: Global Human Rabies Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Human Rabies Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Human Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Human Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Human Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Human Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Human Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Human Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Human Rabies Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Human Rabies Vaccine Market Overview

1.1 Product Definition and Statistical Scope

1.2 Human Rabies Vaccine Product by Type

1.2.1 Global Human Rabies Vaccine Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Vero Cell

1.2.3 BHK

1.2.4 Chick Embryo Cell

1.2.5 Human Diploid Cells

1.2.6 Others

1.3 Human Rabies Vaccine Product by Application

1.3.1 Global Human Rabies Vaccine Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Pre-Exposure Vaccine

1.3.3 Post-Exposure Vaccine

1.4 Global Human Rabies Vaccine Market Revenue and Sales Analysis

1.4.1 Global Human Rabies Vaccine Market Size Analysis (2019-2030)

1.4.2 Global Human Rabies Vaccine Market Sales Analysis (2019-2030)

1.4.3 Global Human Rabies Vaccine Market Sales Price Trend Analysis (2019-2030)

1.5 Human Rabies Vaccine Market Development Status and Trends

1.5.1 Human Rabies Vaccine Industry Development Status Analysis

1.5.2 Human Rabies Vaccine Industry Development Trends Analysis

2 Human Rabies Vaccine Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Human Rabies Vaccine Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Human Rabies Vaccine Market Analysis by Regions

4.1 Human Rabies Vaccine Overall Market: 2023 VS 2024 VS 2030

4.2 Global Human Rabies Vaccine Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Human Rabies Vaccine Revenue and Market Share by Region (2019-2024)

4.2.2 Global Human Rabies Vaccine Revenue Forecast by Region (2025-2030)

4.3 Global Human Rabies Vaccine Sales and Forecast Analysis (2019-2030)

4.3.1 Global Human Rabies Vaccine Sales and Market Share by Region (2019-2024)

4.3.2 Global Human Rabies Vaccine Sales Forecast by Region (2025-2030)

4.4 Global Human Rabies Vaccine Sales Price Trend Analysis (2019-2030)

5 Global Human Rabies Vaccine Market Size by Type and Application

5.1 Global Human Rabies Vaccine Market Size by Type

5.1.1 Global Human Rabies Vaccine Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Human Rabies Vaccine Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Human Rabies Vaccine Market Size by Application

5.2.1 Global Human Rabies Vaccine Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Human Rabies Vaccine Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Human Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Human Rabies Vaccine Market Size by Type

6.3.1 North America Human Rabies Vaccine Sales by Type (2019-2030)

6.3.2 North America Human Rabies Vaccine Revenue by Type (2019-2030)

6.4 North America Human Rabies Vaccine Market Size by Application

6.4.1 North America Human Rabies Vaccine Sales by Application (2019-2030)

6.4.2 North America Human Rabies Vaccine Revenue by Application (2019-2030)

6.5 North America Human Rabies Vaccine Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Human Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Human Rabies Vaccine Market Size by Type

7.3.1 Europe Human Rabies Vaccine Sales by Type (2019-2030)

7.3.2 Europe Human Rabies Vaccine Revenue by Type (2019-2030)

7.4 Europe Human Rabies Vaccine Market Size by Application

7.4.1 Europe Human Rabies Vaccine Sales by Application (2019-2030)

7.4.2 ? Europe Human Rabies Vaccine Revenue by Application (2019-2030)

7.5 Europe Human Rabies Vaccine Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Human Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Human Rabies Vaccine Market Size by Type

8.3.1 China Human Rabies Vaccine Sales by Type (2019-2030)

8.3.2 China Human Rabies Vaccine Revenue by Type (2019-2030)

8.4 China Human Rabies Vaccine Market Size by Application

8.4.1 China Human Rabies Vaccine Sales by Application (2019-2030)

8.4.2 China Human Rabies Vaccine Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Human Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Human Rabies Vaccine Market Size by Type

9.3.1 APAC (excl. China) Human Rabies Vaccine Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Human Rabies Vaccine Revenue by Type (2019-2030)

9.4 APAC (excl. China) Human Rabies Vaccine Market Size by Application

9.4.1 APAC (excl. China) Human Rabies Vaccine Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Human Rabies Vaccine Revenue by Application (2019-2030)

9.5 APAC (excl. China) Human Rabies Vaccine Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Human Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Human Rabies Vaccine Market Size by Type

10.3.1 Latin America Human Rabies Vaccine Sales by Type (2019-2030)

10.3.2 Latin America Human Rabies Vaccine Revenue by Type (2019-2030)

10.4 Latin America Human Rabies Vaccine Market Size by Application

10.4.1 Latin America Human Rabies Vaccine Sales by Application (2019-2030)

10.4.2 Latin America Human Rabies Vaccine Revenue by Application (2019-2030)

10.5 Latin America Human Rabies Vaccine Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Human Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Human Rabies Vaccine Market Size by Type

11.3.1 Middle East & Africa Human Rabies Vaccine Sales by Type (2019-2030)

11.3.2 Middle East & Africa Human Rabies Vaccine Revenue by Type (2019-2030)

11.4 Middle East & Africa Human Rabies Vaccine Market Size by Application

11.4.1 Middle East & Africa Human Rabies Vaccine Sales by Application (2019-2030)

11.4.2 Middle East & Africa Human Rabies Vaccine Revenue by Application (2019-2030)

11.5 Middle East & Africa Human Rabies Vaccine Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Human Rabies Vaccine Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Human Rabies Vaccine Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Human Rabies Vaccine Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Human Rabies Vaccine Average Sales Price by Manufacturers (2020-2024)

12.2 Human Rabies Vaccine Competitive Landscape Analysis and Market Dynamic

12.2.1 Human Rabies Vaccine Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Bharat Biotech

13.1.1 Bharat Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Bharat Biotech Human Rabies Vaccine Product Portfolio

13.1.3 Bharat Biotech Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Bavarian Nordic

13.2.1 Bavarian Nordic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Bavarian Nordic Human Rabies Vaccine Product Portfolio

13.2.3 Bavarian Nordic Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Sanofi-Pasteur

13.3.1 Sanofi-Pasteur Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Sanofi-Pasteur Human Rabies Vaccine Product Portfolio

13.3.3 Sanofi-Pasteur Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Chengda Bio

13.4.1 Chengda Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Chengda Bio Human Rabies Vaccine Product Portfolio

13.4.3 Chengda Bio Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 KANGH

13.5.1 KANGH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 KANGH Human Rabies Vaccine Product Portfolio

13.5.3 KANGH Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Prcmise

13.6.1 Prcmise Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Prcmise Human Rabies Vaccine Product Portfolio

13.6.3 Prcmise Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Henan Grand Biopharma

13.7.1 Henan Grand Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Henan Grand Biopharma Human Rabies Vaccine Product Portfolio

13.7.3 Henan Grand Biopharma Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Zhuoyi Biological

13.8.1 Zhuoyi Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Zhuoyi Biological Human Rabies Vaccine Product Portfolio

13.8.3 Zhuoyi Biological Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Ningbo Rongan Biological

13.9.1 Ningbo Rongan Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Ningbo Rongan Biological Human Rabies Vaccine Product Portfolio

13.9.3 Ningbo Rongan Biological Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 ZhongKe Biopharm

13.10.1 ZhongKe Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 ZhongKe Biopharm Human Rabies Vaccine Product Portfolio

13.10.3 ZhongKe Biopharm Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.11 Indian Immunologicals

13.11.1 Indian Immunologicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Indian Immunologicals Human Rabies Vaccine Product Portfolio

13.11.3 Indian Immunologicals Human Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Human Rabies Vaccine Industry Chain Analysis

14.2 Human Rabies Vaccine Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Human Rabies Vaccine Typical Downstream Customers

14.4 Human Rabies Vaccine Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support